2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

被引：1529

作者：

Catapano, Alberico L. ^{[1
,2
]}

Graham, Ian ^{[3
]}

De Backer, Guy

Wiklund, Olov

Chapman, M. John

Drexel, Heinz

Hoes, Arno W.

Jennings, Catriona S.

Landmesser, Ulf

Pedersen, Terje R.

Reiner, Zeljko

Riccardi, Gabriele

Taskinen, Marja-Riita

Tokgozoglu, Lale

Verschuren, W. M. Monique

Vlachopoulos, Charalambos

Wood, David A.

Luis Zamorano, Jose

机构：

[1] Univ Milan, Dept Pharmacol & Biomol Sci, Via Balzaretti 9, I-20133 Milan, Italy

[2] Multimed IRCCS, Sesto San Giovanni, MI, Italy

[3] Hermitage Med Clin, Cardiol Dept, Suite 36,Old Lucan Rd, Dublin 20, Ireland

来源：

ATHEROSCLEROSIS | 2016年 / 253卷

关键词：

dyslipidaemias; cholesterol; triglycerides; low-density lipoproteins; high-density lipoproteins; apolipoprotein B; lipoprotein remnants; total cardiovascular risk; treatment; lifestyle; drugs; adherence; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; HIGH-DOSE ATORVASTATIN; TYPE-2; DIABETES-MELLITUS; LIPID-LOWERING THERAPY; APOLIPOPROTEIN C-III; ALL-CAUSE MORTALITY; POLYUNSATURATED FATTY-ACIDS; ACUTE MYOCARDIAL-INFARCTION; ABDOMINAL AORTIC-ANEURYSM;

D O I：

10.1016/j.atherosclerosis.2016.08.018

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：281 / 344

页数：64

共 484 条

[1] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].

Abifadel, M ;

Varret, M ;

Rabès, JP ;

Allard, D ;

Ouguerram, K ;

Devillers, M ;

Cruaud, C ;

Benjannet, S ;

Wickham, L ;

Erlich, D ;

Derré, A ;

Villéger, L ;

Farnier, M ;

Beucler, I ;

Bruckert, E ;

Chambaz, J ;

Chanu, B ;

Lecerf, JM ;

Luc, G ;

Moulin, P ;

Weissenbach, J ;

Prat, A ;

Krempf, M ;

Junien, C ;

Seidah, NG ;

Boileau, C .

NATURE GENETICS, 2003, 34 (02) :154-156

[2] Should people at low risk of cardiovascular disease take a statin? [J].

Abramson, John D. ;

Rosenberg, Harriet G. ;

Jewell, Nicholas ;

Wright, James M. .

BMJ-BRITISH MEDICAL JOURNAL, 2013, 347

[3] β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials [J].

AbuMweis, S. S. ;

Jew, S. ;

Ames, N. P. .

EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2010, 64 (12) :1472-1480

[4]

Abumweis Suhad S, 2008, Food Nutr Res, V52, DOI 10.3402/fnr.v52i0.1811

[5] Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome [J].

Adiels, Martin ;

Olofsson, Sven-Olof ;

Taskinen, Marja-Riitta ;

Boren, Jan .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (07) :1225-1236

[6]

AGMON J, 1992, CIRCULATION, V86, P839

[7] THE THEORY OF PLANNED BEHAVIOR [J].

AJZEN, I .

ORGANIZATIONAL BEHAVIOR AND HUMAN DECISION PROCESSES, 1991, 50 (02) :179-211

[8] Statins in stroke prevention and carotid atherosclerosis -: Systematic review and up-to-date meta-analysis [J].

Amarenco, P ;

Labreuche, J ;

Lavallée, P ;

Touboul, PJ .

STROKE, 2004, 35 (12) :2902-2909

[9] Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention [J].

Amarenco, Pierre ;

Labreuche, Julien .

LANCET NEUROLOGY, 2009, 8 (05) :453-463

[10]

Amarenco P, 2006, NEW ENGL J MED, V355, P549

← 1 2 3 4 5 6 7 8 9 10 →